On April 23, we suggested investors take a bullish posture on NVO, the maker of Ozempic (a popular diabetes therapy) and Wegovy (the popular weight loss drug). This article is for paid members - please login or subscribe for access. Username Password Remember Me Forgot Password Share: Mark W. Guthner, CFA Previous Post Apple Inc: AAPLNext PostDollar General: DG You Might Also Like KO: Have a Coke & a Smile April 29, 2020 G’day Australia | EWA February 9, 2026 More on Tesla (TSLA) + Earnings July 29, 2018
You Might Also Like KO: Have a Coke & a Smile April 29, 2020 G’day Australia | EWA February 9, 2026 More on Tesla (TSLA) + Earnings July 29, 2018
